Live feed16:24:10·421dINSIDERFilingvia QuantisnowEVP, Chief Scientific Officer Schultes Birgit C was granted 37,600 shares, increasing direct ownership by 56% to 105,215 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.NTLA· Intellia Therapeutics Inc.Health CareOriginal source
